Athenex Inc ATNXQ

Healthcare Biotechnology

Athenex, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of next-generation products for the treatment of cancer. The Company's segments include Oncology Innovation Platform and Commercial Platform. The Oncology Innovation Platform is engaged in research and development of its drugs. The Commercial Platform is focused on the sales and marketing of its specialty drugs and the market development of its drugs. Its clinical pipeline in the Oncology Innovation Platform is derived from its technologies: Cell Therapy, based on natural killer T (NKT) cells, and Orascovery, based on a P-glycoprotein pump inhibitor. Its product candidates include KUR-501, KUR-502, and KUR-503. KUR-501 is an autologous product in which NKT cells are engineered with a chimeric antigen receptor (CAR) targeting disialoganglioside (GD2). KUR-503 is an allogeneic product in which NKT cells are engineered with a CAR targeting glypican-3.

GREY:ATNXQ - Post by User

Athenex Inc > ATNX & CHMA............

<< Previous

Bullboard Posts

Next >>

Comment by Iseneschalon May 05, 2021 12:59pm

59 Views

Post# 33132842

RE:ATNX & CHMA............

Iseneschal wrote: Check my charts out..........see the similarities ?

ATNX  https://invst.ly/uoyji

CHMA  https://invst.ly/uoyk1

THis is why I use Stop losses regularly

Cheers .....conversely take a look at NMRD.......I just scalped it for about $500

NMRD  https://invst.ly/uoyl6

Ya win some ....and u lose some...just make sure your losses are small